The PD-L1-and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by alpha-PD-L1 or alpha-IL6 antibodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of Leukocyte Biology, Volume 104, Issue 5, November 2018, Pages 969–985
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2023
- Urheber
-
Rolvering, Catherine
Zimmer, Andreas D.
Ginolhac, Aurélien
Margue, Christiane
Kirchmeyer, Mélanie
Servais, Florence
Hermanns, Heike M.
Hergovits, Sabine
Nazarov, Petr V.
Nicot, Nathalie
Kreis, Stephanie
Haan, Serge
Behrmann, Iris
Haan, Claude
- DOI
-
10.1002/JLB.MA1217-495R
- URN
-
urn:nbn:de:bvb:20-opus-226974
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rolvering, Catherine
- Zimmer, Andreas D.
- Ginolhac, Aurélien
- Margue, Christiane
- Kirchmeyer, Mélanie
- Servais, Florence
- Hermanns, Heike M.
- Hergovits, Sabine
- Nazarov, Petr V.
- Nicot, Nathalie
- Kreis, Stephanie
- Haan, Serge
- Behrmann, Iris
- Haan, Claude
- Universität Würzburg
Entstanden
- 2023
Ähnliche Objekte (12)
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
NUP43 promotes PD-L1/nPD-L1/PD-L1 feedback loop via TM4SF1/JAK/STAT3 pathway in colorectal cancer progression and metastatsis
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Analyse der zellulären und löslichen Immuncheckpoint-Komponenten PD-L1 und sPD-L1 beim Nierenzellkarzinom
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
NUP43 promotes PD-L1/nPD-L1/PD-L1 feedback loop via TM4SF1/JAK/STAT3 pathway in colorectal cancer progression and metastatsis
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Analyse der zellulären und löslichen Immuncheckpoint-Komponenten PD-L1 und sPD-L1 beim Nierenzellkarzinom
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
NUP43 promotes PD-L1/nPD-L1/PD-L1 feedback loop via TM4SF1/JAK/STAT3 pathway in colorectal cancer progression and metastatsis
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Analyse der zellulären und löslichen Immuncheckpoint-Komponenten PD-L1 und sPD-L1 beim Nierenzellkarzinom
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?